In Mali, traditional medicine is not a folkloric curiosity. It is, in the words of Prof. Boubacar Diarra, director of the Atelier Luban du Mali, “an important complement to the healthcare system” backed by “very solid popular roots.” In an interview given to the Agence Malienne de Presse (AMAP), this head of the only institution in the world exclusively dedicated to traditional medicine within the network of Chinese Ateliers Luban painted a picture that is both ambitious and clear-eyed about the state of this sector in Mali. A discourse that deserves to be read both for what it says and for what it does not address.
A Sino-Malian cooperation with precise contours
Created in 2019, the Atelier Luban du Mali is part of a global network of technical cooperation institutions supported by China in various developing countries. Its distinctiveness, according to Prof. Diarra, lies in its exclusive focus on traditional medicine — a world first within this network. The institution provides training ranging from the theoretical foundations of Chinese traditional medicine to acupuncture, including Tuina massage, the identification of medicinal plants, and diagnostic protocols specific to traditional approaches.
The Chinese side contributes, according to the Atelier’s director, teachers, educational programs, equipment, and teaching resources. This cooperation framework also relies on partnerships between Malian and Chinese universities. The stated objective is twofold: to train qualified Malian technicians and to organize a dialogue between the medical traditions of both countries.
It should be noted, however, that Sino-African cooperation in the field of health — and more broadly across all strategic sectors — gives rise to diverse interpretations. While the transfer of know-how is real, the question of effective reciprocity, the progressive empowerment of local structures, and the precise terms of institutional partnerships do not emerge clearly from the discourse. The communiqué details neither the volumes of training, nor the number of beneficiaries, nor the mechanisms for evaluating results.
A rich heritage, still fragile structuring
Prof. Diarra recalls that Mali, from the earliest years of its independence, made the political choice to integrate traditional medicine into its healthcare system, notably by creating a specialized research institute described as one of the first of its kind in Africa. This precedence is a genuine asset. It reflects a long-standing political will and institutional continuity that few countries in the region can claim at this level.
Yet the diagnosis drawn by the researcher is unsparing: a large portion of knowledge remains transmitted orally and is insufficiently documented; the manufacture of plant-based products is still predominantly artisanal; the normative and regulatory framework is deemed inadequate; and scientific research on the efficacy and safety of medicinal plants remains in need of strengthening. This assessment is shared by many observers of the sector across the continent.
The ongoing projects at the Atelier Luban focus on the inventory and botanical identification of Malian medicinal plants, the creation of a database, pharmacological studies and safety assessments, as well as the development of plant-based products. The ultimate ambition is the emergence of a genuine sector and a Malian traditional pharmaceutical industry. These are coherent prospects, but their realization will depend on human, financial, and infrastructural resources that remain to be mobilized.
Health sovereignty: a promising concept, demanding conditions
The concept of “health sovereignty” occupies a central place in Prof. Diarra’s discourse. He sees it as an achievable objective, provided that massive investment is made in research, training, and infrastructure, and that locally produced medicines derived from the country’s natural resources can be developed. The implicitly cited model is that of China, which has, in his view, succeeded in valorizing its traditional medicine while also developing modern medicine.
This reference to the Chinese model warrants some nuance. The valorization of Chinese traditional medicine was built on decades of massive public investment, an integrated pharmaceutical industry, a large domestic market, and an active intellectual property policy. Transposing this trajectory to the Malian context — with budgetary constraints, persistent security challenges, and an still undersized healthcare system — requires structural conditions that the interview does not assess.
Furthermore, the question of protecting endogenous knowledge deserves to be raised explicitly. The documentation and valorization of African medicinal plants raises intellectual property issues: who holds the rights to the data collected? Within what legal framework are the results of pharmacological studies protected? These questions, absent from Prof. Diarra’s remarks, nonetheless constitute a central issue in any process of scientific valorization of traditional resources.
What will need to be monitored
The initiative of the Atelier Luban du Mali represents a serious effort to structure a sector that has long remained on the margins of formalized health policies. Prof. Diarra’s advocacy for increased investment in research and training is well-founded and aligns with a continental trend: several African countries are seeking to formalize and valorize their traditional medicine, as seen in initiatives carried out in other regions of the continent.
What remains to be monitored is the concrete translation of these ambitions: Mali’s capacity to mobilize sufficient public funding in a constrained budgetary context, the effectiveness of skills transfer to local actors, the adoption of an appropriate regulatory framework for products derived from traditional medicine, and the capacity to protect endogenous knowledge within the framework of international partnerships. It is these elements, more than declarations of intent, that will make it possible to assess whether Malian traditional medicine effectively becomes a lever for health sovereignty or remains an institutional promise.
Frequently asked questions
What is the Atelier Luban du Mali and when was it created?
The Atelier Luban du Mali is a professional cooperation platform between China and Mali in the field of traditional medicine, created in 2019. According to its director, Prof. Boubacar Diarra, it is presented as the only Atelier Luban in the world entirely dedicated to traditional medicine. It offers theoretical and practical training to Malian learners and promotes exchanges between the medical traditions of both countries.
What training is provided at the Atelier Luban du Mali?
The training covers the theoretical foundations of Chinese traditional medicine, acupuncture, Tuina massage, the identification and preparation of medicinal plants, as well as the diagnosis and management of certain conditions according to traditional approaches. The objective is to train qualified Malian technicians capable of conducting research and valorization work locally.
What are the main challenges facing Malian traditional medicine today?
According to Prof. Diarra, the main challenges are the still predominantly oral transmission of knowledge, its insufficient documentation, the artisanal nature of the manufacture of plant-based products, the weakness of the regulatory and normative framework, and the lack of rigorous scientific research on the efficacy and safety of medicinal plants. The Atelier Luban aims to contribute to the structuring of the sector on these various points.
How can cooperation with China benefit Mali in this area?
According to Prof. Diarra, the Chinese experience can inspire Mali in terms of standardization, documentation, and preservation of traditional knowledge, as well as in methods of pharmacological research and plant safety assessment. China also provides teachers, programs, and equipment. However, the precise conditions of this partnership — particularly questions of intellectual property and reciprocity — remain to be clarified in order to fully assess its benefits for Mali.
